文献速递免疫规划慢病防控与筛查

奥地利HIV感染成人重复年度流感疫苗接种后高血清保护率与几何平均滴度增加

High seroprotection rates and geometric mean titre increases after repeated annual influenza vaccinations in a cohort of HIV-infected adults in Austria.
PubMed 文献 · Vaccine · 2022-05-20

在344名奥地利HIV感染成人中,于三价亚单位流感疫苗接种前和接种后12周检测血凝抑制抗体应答和血清保护率。A/H1N1和B型血清保护率在接种前各年龄组均超90%、接种后接近100%;A/H3N2血清保护率在30岁以下最低(接种前22.2%、接种后50.0%),60岁以上较高(48.4%和83.9%)。既往接种次数多者血清保护率更高,几何平均滴度增长倍数在各年龄组间无显著差异。

要点

  • A/H1N1和B型接种前血清保护率各年龄组均超90%,接种后接近100%。
  • A/H3N2血清保护率30岁以下最低(接种前22.2%、接种后50.0%),60岁以上较高(48.4%和83.9%)。
  • 既往接种≥8次者接种前后血清保护率分别为62.2%和84.2%,无既往接种者为15.0%和57.5%。

核心结论

  • 年轻个体血清保护率较低可能与未接受HIV治疗比例较高及既往流感毒株接触较少有关。
  • 在老年HIV感染患者和重复年度接种后可获得良好的血清保护率。

研究设计与样本

  • 在344名奥地利HIV感染成人中,于三价亚单位流感疫苗接种前和接种后12周测量血凝抑制抗体应答并调查血清保护率。

主要发现

  • 68.3%患者为男性,中位年龄45岁;83.7%病毒载量<50拷贝/mL,中位CD4计数604/µL;304例(88.4%)既往年份曾接种流感疫苗。
  • A/H1N1和B型血清保护率在接种前各年龄组均超90%,接种后接近100%。
  • A/H3N2血清保护率在30岁以下个体接种前后均最低(22.2%和50.0%),60岁以上较高(48.4%和83.9%)。
  • 几何平均滴度增长倍数各年龄组间无显著差异(3.0至4.2,p=0.425)。
  • 既往接种≥8次者接种前后血清保护率分别为62.2%和84.2%,无既往接种者分别为15.0%和57.5%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Vaccination against seasonal influenza is recommended for all HIV-infected persons. Few data have been reported on the effect of repeated annual vaccination in this population. METHODS: We measured haemagglutination inhibition antibody responses and investigated seroprotection rates in 344 HIV-infected adults before and 12 weeks after influenza vaccination with a trivalent subunit vaccine. RESULTS: 68.3% of patients were male, the median age was 45 years. 83.7% had a viral load < 50 copies/mL. The median CD4 count was 604/µL. 304 patients (88.4%) had received influenza vaccinations in previous years. Seroprotection rates for A/H1N1 and B were over 90% in all age groups before vaccination and close to 100% after vaccination. For A/H3N2, seroprotection rates were lowest in individuals below 30 years both before and after vaccination (22.2% and 50.0%) and higher in older age groups (48.4% and 83.9% in people over 60 years). GMT fold increases were not significantly different across the age groups (3.0 to 4.2, p = 0.425). Previous influenza vaccinations were associated with higher seroprotection rates before and after vaccination (62.2% and 84.2% in patients with 8 or more previous vaccinations vs. 15.0% and 57.5% without previous vaccinations, respectively). Individuals with detectable viral load, elevated immune activation (urine neopterin ≥ 250 µmol/mol creatinine), and higher CD4 nadir (≥200 cells/µL) showed a trend towards inferior immune responses to vaccination, whereas gender and CD4 count did not have an effect. CONCLUSION: The lower seroprotection rates observed in younger individuals may be explained by the higher proportion of patients without HIV treatment and with fewer previous encounters with influenza strains. Good seroprotection rates can be achieved in elderly HIV-infected patients and after repeated annual vaccinations.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Kitchen M, Leierer G, Kistner O, et al. High seroprotection rates and geometric mean titre increases after repeated annual influenza vaccinations in a cohort of HIV-infected adults in Austria. Vaccine. 2022. PMID: 35606234. doi:10.1016/j.vaccine.2022.05.004

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。